oxy patch updated on its way, stay tuned, page-14

Hottod, I believe ( and this is only my opinion)that the point of todays ann was to state that the formulation has now been finalised and the final patch design ( of the many they have been testing) has been selected which now clears the way for POH to enter the clinic as scheduled. This is the patch that Esra wants to take all the way to the FDAs front door- so it is a very significant milestone and Ann.. The Oxymorphone trial has not been delayed in any way and nor does this ann hint or hide any other form of delay to the clinical program. There is no need to over analyse ( with respect) this very straight forward ann. The POH train has just moved up a gear and been further derisked on the back of this release.